CENTER OF URBAN RES & EDUCATION IN DIABETES AND METABOLISM

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 具体目标 查尔斯·德鲁医学与科学大学（CDU）将继续通过专门的“糖尿病和代谢城市研究和教育中心”（CUREDM）加强其临床卓越研究中心（CCLE）的活动。指导该中心活动的目的是增加从事临床研究的研究科学家的临界质量，并增加在德鲁进行的糖尿病和代谢相关的临床研究。糖尿病是《2010年健康人》的重点领域之一，这是国家健康议程的蓝图。此外，德鲁大学独特的患者群体包括大约54%的西班牙裔，34%的非洲裔美国人，7%的白人和5%的亚洲/太平洋岛民患有糖尿病和代谢相关疾病的人比例过高。 这项申请的总体具体目标是： 1.增加糖尿病和代谢相关临床研究人员的临界质量; 2.通过支持导师研究试点项目，将有奉献精神的高级研究人员与有前途的初级教师配对，促进教师发展; 3.通过提供一个有利于科学发现和短期课程和/或德鲁大学正式学位培训的环境，提高初级研究人员的职业生涯; 4.通过两个创新的研究核心，在严格的临床研究方法的背景下改善糖尿病和代谢紊乱患者的预后：1）转化研究核心，将与德鲁的研究密集型合作伙伴加州大学洛杉矶分校合作; 2）身体成分和代谢核心; 5.增加知识和研究活动（赠款提交和采购、演讲和出版物），特别是在糖尿病和代谢紊乱方面，因为它们与改善妇女、少数民族/种族和其他弱势群体的保健有关。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. SPECIFIC AIMS Charles Drew University of Medicine and Science (CDU) will continue to enhance its Clinical Center for Research Excellence (CCRE) activities through the specialized "Center of Urban Research and Education in Diabetes and Metabolism" (CUREDM). The purposes guiding the center's activities are to increase the critical mass of research scientists engaged in clinical research and to increase diabetes and metabolic-related clinical research conducted at Drew. Diabetes is one of the key focus areas of Healthy People 2010, the blueprint for the nation's health agenda. In addition, the unique patient population at Drew Universitycomprised of approximately 54 percent Hispanics, 34 percent African Americans, 7 percent whites, and 5 percent Asian/Pacific Islanderssuffers disproportionately from diabetes and metabolic-related disorders. The overall specific aims for this application are: 1.To increase the critical mass of diabetes and metabolic-related clinical researchers; 2.To promote faculty development through the support of mentored-research pilot projects by pairing dedicated senior investigators with promising junior faculty; 3.To enhance the careers of junior investigators by providing an environment that facilitates scientific discovery and short-term curricula and/or formal degree training at Drew University; 4.To improve diabetes and metabolic disorder patient outcomes in the context of methodologically rigorous clinical research through two innovative research cores: 1) The Translational Research Core, which will collaborate with Drew's research-intensive partner, UCLA; and 2) the Body Composition and Metabolism Core; and 5.To increase the body of knowledge and research activity (grant submissions and procurement, presentations, and publications), especially in diabetes and metabolic disorders as they relate to improving the health care of women, ethnic/racial minorities, and other disadvantaged populations.